Hydroxychloroquine prophylaxis in Covid 19 infectio
- Registration Number
- CTRI/2020/05/025010
- Lead Sponsor
- Indian council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All healthcare workers (including doctors, nurses, and other hospital staff) employed by COVID-19 dedicated hospitals, irrespective of their HCQ consumption status, who test negative at the baseline and consent to be included in the study will be eligible for recruitment in the study
Healthcare workers who are pregnant or lactating will be excluded based on self-declaration of such status at the baseline evaluation. Those who do not consent to participate will also be excluded. If tested to be COVID-19 positive at baseline, the healthcare worker will be excluded from the study, isolated and managed under standard treatment protocols.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of healthcare workers who likely contracted COVID-19 infection from a nosocomial source in the 12-week period during which they were under HCQ prophylaxisTimepoint: Every week for 12 weeks
- Secondary Outcome Measures
Name Time Method The proportion of healthcare workers who develop adverse drug reactions in the 12-week period during which they were under HCQ prophylaxisTimepoint: Every week for 12 weeks